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People with severe mental illnesses, such as schizophrenia,
depression or bipolar disorder, have worse physical health
and reduced life expectancy compared to the general
population. The excess cardiovascular mortality associated
with schizophrenia and bipolar disorder is attributed to an
increased risk of the modifiable coronary heart disease risk
factors, obesity, smoking, diabetes, hypertension, and
dyslipidaemia.
Antipsychotic medication and possibly other psycho-
tropic medication like antidepressants can induce weight
gain and further increase the risk of adverse metabolic
effects which may result in further increased incidence
of cardiovascular disease. Patients have limited access to
general healthcare with less opportunity for cardiovascu-
lar risk screening and prevention than would be
expected in a non-psychiatric population.
The European Psychiatric Association (EPA), sup-
ported by the European Association for the Study of
Diabetes (EASD) and the European Society of Cardiol-
ogy (ESC) published this statement aiming to improve
the care of patients suffering from severe mental illness.
The intention is to initiate co-operation and shared care
between the different healthcare professionals and to
increase the awareness of psychiatrists caring for
patients suffering from severe mental illness to screen
and treat increased cardiovascular risk factors and
diabetes.
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